New study tests quick COVID-19 treatments to shorten illness
NCT ID NCT05954286
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether early treatment or preventive medication can help adults with COVID-19 feel better faster. 92 participants took part, and researchers tracked their symptoms daily for 28 days. The goal was to see if the treatments could reduce how long symptoms last and how severe they are.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
-
Josha Research
Bloemfontein, 9300, South Africa
-
KUR Research
Nashville, Tennessee, 37209, United States
-
Makerere University Walter Reed Project
Fort Portal, Uganda
-
Royal Thai Army Clinical Research Center (RTA CRC) Royal Thai Army-Armed Forces Research Institute of Medical Sciences (RTA-AFRIMS)
Bangkok, 10400, Thailand
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill keep High-Risk COVID-19 patients out of the hospital?
- Could a five-day pill course cut COVID-19 deaths? czech nationwide data puts molnupiravir to the test.
- Millions of vaccine records scoured for rare side effects
- Scientists probe why lung disease raises COVID-19 risk
- New rapid test could spot COVID and flu in minutes
- New saliva test could diagnose COVID-19 in under an hour